Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Directorate Change

1 Apr 2025 17:05

RNS Number : 2194D
Maven Income & Growth VCT 4 PLC
01 April 2025
 

Maven Income and Growth VCT 4 PLC

 

Directorate Changes

 

Appointment of Director

 

The Board of Maven Income and Growth VCT 4 PLC (the Company) is pleased to announce the appointment of Daniel Bittner as an independent Non-executive Director, with effect from 1 April 2025.

 

Daniel has an MBA from the University of St Gallen and worked in the financial sector with JP Morgan, Morgan Stanley and Goldman Sachs before founding the Rhino Partners Real Estate Group in Germany, and acting as a board advisor to Alpha Credit, a Geneva based private debt specialist. In 2002, he founded Arsago Capital Partners AG, of which he is chief executive, where he has managed direct and portfolio investments, including a global macro hedge fund, equity funds, a fixed income arbitrage fund, private equity investments, debt financing and venture capital mining companies.

 

During his career, Daniel has gained experience in business development, deal sourcing, investment valuation and oversight, and the structuring and risk assessment of investment portfolios. He has also managed funds, developed investment strategies, assessed project feasibility studies and overseen the execution of real estate and mining projects, as well as providing services as an investment advisor, focusing on private equity investments in the commodity, energy, real estate and technology sectors.

 

Daniel will serve on the Company's Audit, Management Engagement, Nomination and Risk Committees, and will stand for election by Shareholders at the Annual General Meeting (AGM) to be held on 8 May 2025.

 

As at the date of this announcement, Daniel has no current beneficial interest in the Company's Ordinary Shares and, in relation to his appointment, there is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 R.

 

Retirement of Director

As required by Listing Rule 9.6.11, the Company also confirms that Steven Scott, who has served as an independent Non-executive Director since 1 September 2004 and as Chair of the Audit Committee, has decided to retire at the conclusion of the 2025 AGM and will not stand for re-election.

 

The Board would like to thank Steven for his many years of commitment to the Company in his role as Non-executive Director and as Chair of the Audit Committee, and wishes him every success for the future.

 

Following Steven's retirement, Brian Colquhoun will assume the role of Chair of the Audit Committee.

 

Maven Capital Partners UK LLP

Company Secretary

 

1 April 2025

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUARNRVOUSRAR
Date   Source Headline
20th May 20109:07 amRNSTransaction in Own Shares
18th May 201012:15 pmRNSInterim Management Statement
10th May 201011:38 amRNSTotal Voting Rights
7th May 201011:22 amRNSAnnual Information Update
7th May 201011:04 amRNSTransaction in Own Shares
6th May 20103:41 pmRNSResult of AGM
4th May 20102:46 pmRNSIssue of Equity
6th Apr 201012:32 pmRNSTransaction in Own Shares
6th Apr 201011:25 amRNSIssue of Equity
1st Apr 20105:22 pmRNSIssue of Equity
31st Mar 201011:30 amRNSAnnual Financial Report
10th Mar 20103:34 pmRNSNet Asset Value(s)
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
5th Jan 201011:21 amRNSTotal Voting Rights
23rd Dec 200911:42 amRNSChange of Name
22nd Dec 20095:23 pmRNSTransaction in Own Shares
18th Dec 200910:04 amRNSStatement re result of General Meeting
16th Dec 200911:48 amRNSTransaction in Own Shares
18th Nov 20091:00 pmRNSNotice of EGM
16th Nov 200912:04 pmRNSInterim Management Statement - Amendment
16th Nov 200911:13 amRNSInterim Management Statement - Amendment
16th Nov 200910:16 amRNSInterim Management Statement
2nd Nov 20094:37 pmRNSChange of Adviser
7th Aug 200912:16 pmRNSHalf Yearly Report
10th Jun 200911:53 amRNSChange of Adviser
1st Jun 200911:30 amRNSAnnual Information Update
15th May 200910:22 amRNSResult of AGM
15th May 200910:12 amRNSInterim Management Statement
7th Apr 200910:52 amRNSDividend Declaration
6th Apr 20094:22 pmRNSAnnual Financial Report
6th Apr 20093:00 pmRNSChange of Adviser
14th Nov 200811:37 amRNSResult of EGM
14th Nov 200811:14 amRNSInterim Management Statement
29th Aug 200812:19 pmRNSCircular re GM, and issue of
14th Aug 200811:31 amRNSInterim Results
7th Aug 200812:49 pmRNSDirectorate Change
19th May 20083:30 pmRNSInterim Management Statement
15th May 20083:50 pmRNSAGM Statement
7th May 20089:30 amRNSAnnual Information Update
6th May 200811:36 amRNSAnnual Report and Accounts
12th Mar 200811:00 amRNSDividend Declaration
28th Feb 20084:36 pmRNSFinal Results
12th Sep 20072:56 pmRNSInterim Results
1st Aug 20071:19 pmRNSTotal Voting Rights
1st Aug 20071:15 pmRNSIssue of Equity
13th Jul 20073:06 pmRNSIssue of Equity
28th Jun 20074:20 pmRNSExtension of Offer period

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.